As of today (2026-06-30), Cellev8 Nutrition's weighted average cost of capital is 19.39%%. Cellev8 Nutrition's ROIC % is 0.00% (calculated using TTM income statement data).
Cellev8 Nutrition earns returns that do not match up to its cost of capital. It will destroy value as it grows.
For a comprehensive WACC calculation, please access the WACC Calculator.
Cellev8 Nutrition (OTCPK:CELV) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Cellev8 Nutrition's weighted average cost of capital is 19.39%%. Cellev8 Nutrition's ROIC % is 0.00% (calculated using TTM income statement data).
Cellev8 Nutrition earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.
Related Terms
Cellev8 Nutrition WACC % Historical Data
* Premium members only.
The historical data trend for Cellev8 Nutrition's WACC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Cellev8 Nutrition's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellev8 Nutrition WACC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Cellev8 Nutrition's WACC % distribution charts can be found below:
* The bar in red indicates where Cellev8 Nutrition's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Cellev8 Nutrition's market capitalization (E) is $6.739 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Nov. 2015, Cellev8 Nutrition's latest one-year annual average Book Value of Debt (D) is $3.87 Mil.
a) weight of equity = E / (E + D) = 6.739 / (6.739 + 3.87) = 0.6352
b) weight of debt = D / (E + D) = 3.87 / (6.739 + 3.87) = 0.3648
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.43%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Cellev8 Nutrition's beta is 3.6956.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.43% + 3.6956 * 6% = 26.6036%
3. Cost of Debt:
GuruFocus uses latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.
As of Nov. 2015, Cellev8 Nutrition's interest expense (positive number) was $0.264 Mil. Its total Book Value of Debt (D) is $3.87 Mil.
Cost of Debt = 0.264 / 3.87 = 6.8217%.
4. Multiply by one minus annual Tax Rate:
GuruFocus uses the most recent annual Tax Expense divided by the most recent annual Pre-Tax Income to calculate the tax rate. The calculated annual tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated annual Tax Rate = 0 / -1.817 = 0%.
Cellev8 Nutrition's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC
=
E / (E + D)
*
Cost of Equity
+
D / (E + D)
*
Cost of Debt
*
(1 - Tax Rate)
=
0.6352
*
26.6036%
+
0.3648
*
6.8217%
*
(1 - 0%)
=
19.39%
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellev8 Nutrition (CELV) has a WACC % of 19.39% as of Jun. 30, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Cellev8 Nutrition and its competitors.
Is Cellev8 Nutrition's WACC % too high?
Cellev8 Nutrition's current WACC % is 19.39%. The Consumer Packaged Goods industry median WACC % is 7.69. Cellev8 Nutrition's value of 19.39% is 152.1% above this industry median. Overall, Cellev8 Nutrition has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cellev8 Nutrition's WACC % compare to LFVN and MAMA?
Cellev8 Nutrition's WACC % of 19.39% can be compared against companies in the Consumer Packaged Goods industry. The industry median WACC % is 7.69. Cellev8 Nutrition's value of 19.39% is 152.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Consumer Packaged Goods company?
The median WACC % among Consumer Packaged Goods companies is 7.69, based on 2,034 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cellev8 Nutrition's current WACC % of 19.39% is 152.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Cellev8 Nutrition and its competitors. For the Consumer Packaged Goods industry, the median WACC % is 7.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellev8 Nutrition's current WACC % is 19.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellev8 Nutrition stock overvalued right now?
Cellev8 Nutrition (CELV) has a current WACC % of 19.39%. The current WACC % is 19.39% and 152.1% above the Consumer Packaged Goods industry median of 7.69. Cellev8 Nutrition's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Cellev8 Nutrition (CELV), the current WACC % is 19.39% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score
Get the complete analysis for CELV
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CELV has been successfully added to your 